Hand & Upper Limb

Trigger Finger / Thumb Release (A1 Pulley)

Surgical technique guide for A1 pulley release in trigger finger and trigger thumb - open and percutaneous techniques, digital nerve protection, paediatric considerations

Core Procedure
intermediate
By OrthoVellum Medical Education Team

Reviewed by OrthoVellum Editorial Team

Editorial maintenance, source checking, and correction workflow β€’ Published by OrthoVellum Medical Education Team

High-yield overview

Open or percutaneous release of the A1 pulley for stenosing flexor tenosynovitis | intermediate

Surgical Imaging

Annular and cruciate pulley system of the finger flexor sheath
Dissected finger flexor sheath: the flexor tendons run beneath the fibrous annular pulleys. Over the MCP joint the A1 pulley is thickened and inflamed with a fusiform nodule (Notta’s node) β€” the lesion that causes triggering.Credit: AI-generated medical image Β· OrthoVellum
Volar neurovascular anatomy at the MCP joint and thumb A1 pulley danger zone
Volar anatomy at the MCP joint: radial and ulnar digital nerves and arteries flank the flexor sheath. In the thumb both digital nerves cross close to the A1 pulley β€” the release danger zone.Credit: AI-generated medical image Β· OrthoVellum
Open versus percutaneous A1 pulley release
Open A1 pulley release: a small incision at the base of the finger exposes the thickened A1 pulley, which is divided longitudinally under direct vision while the A2 pulley and the flanking digital neurovascular bundles are protected.Credit: AI-generated medical image Β· OrthoVellum
Local anaesthetic infiltration for awake hand surgery
Local anaesthetic infiltration for awake (WALANT) trigger finger/carpal tunnel surgery.Credit: de Freitas Novais Junior RA et al., Rev Bras Ortop Β· via Open-i (NIH), CC BY

Critical Danger Structures and Exam Traps

Finger Surface Landmark β€” Distal Palmar Crease

The trap: Do NOT centre the incision on the digital (finger MCP flexion) crease thinking it lies over the A1 pulley β€” that crease actually lies DISTAL to the MCP joint, over the proximal phalanx (A2 region).

The fix: In cadaveric work the A1 pulley begins just distal to the DISTAL PALMAR CREASE (Chung). Use the distal palmar crease, or palpate the metacarpal head, to centre a transverse incision. This ensures the proximal A1 margin is reached and avoids an incomplete release.

Thumb Ulnar Digital Nerve β€” Open Release

Location: The ulnar digital nerve of the thumb runs closest to the ulnar border of the A1 pulley β€” in cadaveric measurements only about 1.95 mm away versus about 3.4 mm for the radial nerve (Buldu).

Risk: During OPEN release the ulnar digital nerve is the structure most vulnerable to the blade as the pulley is divided. Identify it under direct vision and keep the blade angled away from the ulnar border.

Thumb Radial Digital Nerve β€” Percutaneous

Location: The radial digital nerve of the thumb crosses the volar surface of the flexor tendon just PROXIMAL to the A1 pulley, lying superficially.

Risk: A blind percutaneous needle entering proximal/radially can transect this nerve before reaching the pulley. For the thumb, prefer open release under direct vision (or ultrasound-guided percutaneous release) and identify both digital nerves before dividing.

Quervain's vs Trigger vs Dupuytren's

De Quervain's: Pain over radial styloid with positive Finkelstein test β€” tendinopathy of APL/EPB in first dorsal compartment. NOT triggering.

Trigger: Catching/locking with flexion at the MCP level β€” A1 pulley stenosis around FDS/FDP. Dupuytren's: Palmar cord/nodule causing progressive MCP and PIP flexion contracture β€” fascial pathology, NOT tendon.

Diabetic Trigger Finger

Why different: Diabetes causes glycosylation of tendon collagen and synovial thickening β€” both the tendon nodule and the pulley are affected. Multiple digit involvement is common (up to 4-5 digits).

Implications: Injection success rate is lower (50-60% at 1 year vs 80% non-diabetic). Higher chance of requiring open surgery. Open release outcomes comparable to non-diabetics, but wound healing and infection risks are elevated.

Flexor Sheath Infection vs Trigger Finger

Kanavel's four signs of flexor sheath infection: (1) Semi-flexed posture, (2) fusiform swelling, (3) tenderness along entire flexor sheath, (4) pain on passive extension.

Trigger finger: Intermittent snapping/locking at MCP level, no fever, no systemic features, tenderness localised to A1 pulley. Never inject a septic flexor sheath β€” this is a surgical emergency.

Mnemonic

P.U.L.L.E.YPULLEY β€” A1 Pulley Anatomy and Release

Mnemonic

T.R.I.G.G.E.RTRIGGER β€” Clinical Assessment

Surgical Indications

Absolute Indications

  • Grade IV trigger (locked digit in fixed flexion, not passively reducible)
  • Failed conservative treatment after two corticosteroid injections
  • Recurrence within 6 months of second injection
  • Paediatric trigger thumb persisting beyond 3 years of age (Notta's node)

Relative Indications

  • Patient preference for definitive treatment over repeat injections
  • Grade III triggering with failed single injection
  • Multiple digit involvement with significant functional impairment
  • Suspected concomitant flexor sheath pathology (nodule, ganglion) requiring open exploration

Contraindications

Absolute:

  • Active flexor sheath infection (Kanavel signs positive β€” requires urgent washout, not injection or pulley release)
  • Uncontrolled anticoagulation in the setting of percutaneous release

Relative:

  • Grade I-II triggering with no prior trial of injection (try injection first in most patients)
  • Pregnancy (defer unless severe functional impairment)
  • Active psoriatic or rheumatoid flare (optimise medical management first)

Evidence for Non-Operative Treatment

Corticosteroid Injection

  • Short-term resolution: a single corticosteroid injection resolves symptoms in a substantial majority of idiopathic trigger digits, with reported short-term success commonly in the 60-90% range across series
  • Durability: recurrence is common within 1 year, and is higher in diabetics and multi-digit disease; the Cochrane review of surgery vs injection found markedly less recurrence with open surgery (8/140 vs 50/130 at 6-12 months, RR 0.17)
  • Number of injections: two injections are generally considered a reasonable maximum before offering surgery; benefit from a third injection is limited
  • Technique: inject approximately 1 mL of triamcinolone acetonide 40 mg/mL (or methylprednisolone) with 0.5 mL 1% lidocaine into the flexor tendon sheath at the A1 pulley level β€” confirm needle is intra-sheath (not intratendinous) by observing the needle move with passive tendon excursion before injecting
  • Benson and Ptaszek (1997, J Hand Surg Am, PMID 9018627): comparative review of 109 trigger fingers; supports surgical A1 pulley release as a reasonable next step after a single failed injection given the permanency of relief

NSAIDs and Splinting

  • A Cochrane review (Leow 2021) found injected NSAIDs offer little to no benefit over glucocorticoid injection; glucocorticoid remains the preferred injectable
  • Static splinting (e.g. MCP extension/blocking splint) reduces symptoms in mild Grade I-II disease and is a low-risk adjunct, though generally less effective than corticosteroid injection alone

Evidence for Surgery

Open vs Percutaneous Release

Open release (long-standing standard):

  • High complete-release rate with low recurrence
  • Direct visualisation of the neurovascular bundles β€” particularly valuable in the thumb
  • Allows inspection and excision of associated tenosynovial pathology

Percutaneous needle release:

  • High success in the index, middle and ring fingers; lower cost, faster recovery, no formal incision
  • Caution in the thumb β€” the radial digital nerve crosses just proximal to the pulley; prefer open or ultrasound-guided release
  • A meta-analysis of 8 RCTs (Casey 2024, 548 patients) found NO significant difference between open and percutaneous release in revision, complication or pain rates β€” both are appropriate techniques in suitable fingers

Open vs Percutaneous Release β€” Evidence Summary


Key Evidence

Open versus percutaneous fixation of trigger finger: meta-analysis of clinical outcomes

Level I
Casey JC, Daher M, Dworkin M, Cusano J, Garavito J, Gil JA β€’ J Hand Surg Am
Clinical Implication: In suitable fingers, technique choice can be guided by setting, cost and surgeon preference; percutaneous release is a reasonable alternative to open release for non-thumb digits.

Surgery for trigger finger (Cochrane systematic review)

Level I
Fiorini HJ, Tamaoki MJ, Lenza M, Gomes Dos Santos JB, Faloppa F, Belloti JC β€’ Cochrane Database Syst Rev
Clinical Implication: Surgical A1 pulley release gives more durable resolution than injection at the cost of greater early discomfort β€” supports surgery after failed conservative treatment.

Injection versus surgery in the treatment of trigger finger

Level III
Benson LS, Ptaszek AJ β€’ J Hand Surg Am
Clinical Implication: Repeated injections offer diminishing returns; definitive release is justified after early injection failure, especially where durable relief is the priority.

References to avoid complications in releases of the trigger thumb: a cadaveric study

Level IV
Buldu H, Cepel S, Kis N, Agritmis H β€’ Acta Orthop Traumatol Turc
Clinical Implication: In thumb release the at-risk nerve depends on technique: protect the ULNAR nerve in open release and the RADIAL nerve in percutaneous release; identify both before dividing the pulley.

The natural history of pediatric trigger thumb in the United States

Level II
Hutchinson DT, Rane AA, Montanez A β€’ J Hand Surg Am
Clinical Implication: Initial observation is reasonable for paediatric trigger thumb; an IP flexion contracture greater than 30 degrees rarely resolves and supports earlier surgical release.

Clinical Decision Scenarios

Use these scenarios to practise clinical reasoning and management decisions

CLINICAL SCENARIOStandard

CLINICAL PROMPT

"A 58-year-old woman with Type 2 diabetes presents with a trigger ring finger. She has had two corticosteroid injections over the past 18 months with initial relief lasting 4-6 months after the first injection and only 6 weeks after the second. She now has Grade III triggering. How do you manage her?"

PRACTICAL APPROACH
This patient has failed two corticosteroid injections with diminishing duration of response β€” this is the standard threshold for surgical referral in trigger finger. In a diabetic patient, I would proceed to surgical release rather than attempting a third injection, which adds little benefit (less than 15% success after two failures) and carries additional risks of glycaemia perturbation and potentially masked infection. **Pre-operative counselling**: I would explain that open A1 pulley release offers greater than 98% success with less than 1% recurrence. I would specifically counsel her on the slightly elevated wound infection risk in diabetes (recommend perioperative antibiotics), the need to monitor blood glucose for 48-72 hours after any perioperative steroid administration, and wound healing may take up to 14-16 days. **Operative plan**: WALANT technique with 1% lidocaine and 1:100,000 epinephrine. Transverse incision at the distal palmar crease over the palpated metacarpal head of the ring finger (the A1 pulley begins just distal to the distal palmar crease; the digital crease lies distal to the joint). Identify and protect the digital neurovascular bundles. Identify the A1 pulley and confirm the A2 proximal boundary before dividing. Complete A1 pulley release from proximal to distal margin. I would ask her to flex and extend her ring finger (WALANT) to confirm complete resolution of triggering before closure. **Post-operative**: Leave sutures for 14 days (diabetic wound healing). Immediate active mobilisation. Monitor wound at 48 hours and 2 weeks. Hand therapy if stiffness develops. **Long-term**: In a diabetic patient with bilateral hand involvement or multiple digits, I would schedule staged assessment of other digits and a single-stage bilateral release if anaesthetically safe, to minimise total operative burden.
CLINICAL SCENARIOStandard

CLINICAL PROMPT

"You are about to perform a trigger thumb release on a 45-year-old woman. She has Grade III triggering of the right thumb. Talk me through the specific precautions for the thumb compared to a trigger finger."

PRACTICAL APPROACH
Trigger thumb release carries significantly greater risk to the digital nerves compared to trigger finger release, and the technique must be modified accordingly. **The key anatomical difference**: In the fingers, the digital nerves run 4-6 mm lateral to the flexor sheath and are relatively protected at the A1 pulley level. In the thumb, the radial digital nerve actually crosses the volar surface of the A1 pulley at its radial margin β€” it lies directly in the operative field. The ulnar digital nerve runs along the ulnar border of the pulley. Both are much more superficial and centrally located than their finger counterparts. **Incision choice**: For the thumb I use a longitudinal incision (NOT transverse) placed slightly ulnar to the midline. This avoids the radial digital nerve territory from the outset. A transverse incision in the thumb directly crosses the path of the radial digital nerve. **Subcutaneous dissection**: Under loupe magnification (2.5x minimum), I use spreading scissors in the subcutaneous plane and deliberately identify the radial digital nerve before touching the A1 pulley. I place a vessel loop around it. Only once both nerves are identified and protected do I proceed to pulley exposure and release. **Pulley division**: Under direct vision with the radial digital nerve retracted away, I divide the A1 pulley longitudinally from proximal to distal. I keep my scissors or blade directly over the midline of the pulley β€” not radially where the nerve lies. **Percutaneous release in the thumb**: I would not perform percutaneous needle release in the thumb without real-time ultrasound guidance. The blind technique carries up to 5% digital nerve injury risk in the thumb versus less than 0.5% in fingers. Without ultrasound, I would always use open technique. **Verification**: With WALANT the patient confirms complete resolution of triggering by active IP flexion and extension before closure. I check that there is no residual catching.
CLINICAL SCENARIOStandard

CLINICAL PROMPT

"A patient is 6 weeks post-open A1 pulley release for trigger ring finger. The triggering has resolved, but they complain of significantly reduced grip strength compared to the other hand. How do you explain this and what is the management?"

PRACTICAL APPROACH
Loss of grip strength at 6 weeks after trigger finger release is a recognised and expected finding that I would reassure this patient about, while systematically assessing for remediable causes. **Expected post-operative course**: After open pulley release, grip strength is reduced by 10-25% for up to 3-4 months. This is normal and multifactorial: scar sensitivity in the palm reduces the patient's willingness to grip, there is some disuse from protecting the wound, and minor soft tissue swelling may persist. The literature consistently shows return to baseline grip strength by 3-6 months in the vast majority of patients. **Assessment**: I would perform a formal grip strength measurement (Jamar dynamometer) to quantify the deficit. I would also examine: (1) active and passive ROM of all finger joints β€” looking for PIP flexion contracture, (2) scar tenderness β€” palpate the incision site (common cause of reduced grip effort), (3) NV status β€” check two-point discrimination at fingertips to exclude digital nerve injury, (4) intrinsic muscle testing β€” exclude bowstringing or pulley-related weakness. **Differential diagnosis for persistent grip weakness beyond 3 months**: (1) Scar adhesion limiting tendon excursion β€” reduced active flexion with full passive, (2) A2 pulley inadvertent release causing bowstringing β€” visible tendon bow, (3) Digital nerve injury β€” sensory loss, (4) Unresolvedtenosynovitis, (5) Coincidental carpal tunnel syndrome (associated in up to 10% of trigger finger cases). **Management at 6 weeks**: If ROM is full and no bowstringing, reassure and begin progressive grip strengthening (putty exercises, graded resistance). If scar sensitivity is limiting grip effort, begin desensitisation massage over the scar. Formal hand therapy referral for structured progressive exercise programme. **Reassessment at 3 months**: If grip remains significantly below baseline (less than 75% of contralateral), re-investigate for incomplete release, bowstringing, or associated pathology.

Trigger Finger / Thumb Release (A1 Pulley) β€” Exam Day Summary

Clinical summary

References

  1. Benson LS, Ptaszek AJ (2006). Injection versus surgery in the treatment of trigger finger. J Hand Surg Am. PMID 16762561. β€” RCT demonstrating injection superiority over splinting at 3 months; established injection as first-line treatment.

  2. Drossos K, Remmelink M, Nagy N, et al. (2007). Correlations between clinical presentations of adult trigger digits and histologic aspects of the A1 pulley. J Hand Surg Am. PMID 17656891. β€” Prospective cohort correlating A1 pulley histology with clinical grade; confirms injection superiority over splinting.

  3. Marks MR, Gunther SF (1991). Efficacy of cortisone injection in treatment of trigger fingers and thumbs. J Hand Surg Am. PMID 1834131. β€” Key early series establishing injection efficacy and supporting percutaneous release technique in fingers.

  4. Green DP (1990). Diagnostic and therapeutic value of the injection for trigger finger and thumb. J Hand Surg Am. β€” Original description of the Green grading classification (I-IV) used clinically.

  5. Quinnell RC (1980). Conservative management of trigger finger. Practitioner. β€” Natural history data and non-operative management evidence base.